BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 2961048)

  • 1. Defects of autologous mixed lymphocyte reaction-activated immunoregulatory T cells in patients with systemic lupus erythematosus.
    Koide J; Takeuchi T; Hosono O; Takano M; Abe T
    Scand J Immunol; 1987 Oct; 26(4):363-9. PubMed ID: 2961048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective expression of the 2H4 molecule after autologous mixed lymphocyte reaction activation in systemic lupus erythematosus patients.
    Takeuchi T; Tanaka S; Steinberg AD; Matsuyama T; Daley J; Schlossman SF; Morimoto C
    J Clin Invest; 1988 Oct; 82(4):1288-94. PubMed ID: 2971675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of suppression following autologous mixed lymphocyte reaction; role of a novel 2H4 antigen.
    Takeuchi T; Rudd CE; Schlossman SF; Morimoto C
    Eur J Immunol; 1987 Jan; 17(1):97-103. PubMed ID: 2949986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct demonstration of immunoregulatory T-cell defects in patients with systemic lupus erythematosus.
    Koide J; Takano M; Takeuchi T; Hosono O; Amano K; Homma M; Abe T
    Scand J Immunol; 1986 Apr; 23(4):449-59. PubMed ID: 2939553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between systemic lupus erythematosus T cell subsets, anti-T cell antibodies, and T cell functions.
    Morimoto C; Reinherz EL; Distaso JA; Steinberg AD; Schlossman SF
    J Clin Invest; 1984 Mar; 73(3):689-700. PubMed ID: 6231307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responder cells in the human autologous mixed lymphocyte reaction (AMLR). Characterization and interactions in healthy individuals and patients with systemic lupus erythematosus.
    Smolen JS; Siminovitch K; Luger TA; Steinberg AD
    Behring Inst Mitt; 1983 May; (72):135-42. PubMed ID: 6242332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal T cell regulation of IgG synthesis in systemic lupus erythematosus.
    Nies KM; Stevens RH; Louie JS
    J Clin Lab Immunol; 1980 Sep; 4(2):69-75. PubMed ID: 6449594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-2 normalizes defective suppressor T cell function of patients with systemic lupus erythematosus in vitro.
    Volk HD; Diamantstein T
    Clin Exp Immunol; 1986 Dec; 66(3):525-31. PubMed ID: 2952381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic lupus erythematosus with deficiency of the T4 epitope on T helper/inducer cells.
    Stohl W; Crow MK; Kunkel HG
    N Engl J Med; 1985 Jun; 312(26):1671-8. PubMed ID: 2582253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired immunoregulation in systemic lupus erythematosus: defective adenosine-induced suppressor T lymphocyte generation.
    Kammer GM; Birch RE; Polmar SH
    J Immunol; 1983 Apr; 130(4):1706-12. PubMed ID: 6220065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of immune regulatory circuits among OKT4+ cells by autologous mixed lymphocyte reactions.
    Kotani H; Takada S; Ueda Y; Murakawa Y; Suzuki N; Sakane T
    Clin Exp Immunol; 1984 May; 56(2):390-8. PubMed ID: 6234113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of immune functions of patients with systemic lupus erythematosus. I. Dysfunction of suppressor T-cell activity related to impaired generation of, rather than response to, suppressor cells.
    Sakane T; Steinberg AD; Green I
    Arthritis Rheum; 1978; 21(6):657-64. PubMed ID: 153749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human T-lymphocyte subpopulations: alterations in systemic lupus erythematosus.
    Moretta A; Mingari MC; Santoli D; Perlmann P; Moretta L
    Scand J Immunol; 1979; 10(3):223-8. PubMed ID: 160613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic suppression of polyclonal immunoglobulin production in normals and patients with systemic lupus erythematosus.
    Clough JD; Krakauer RA; Frank SA; Calabrese LH
    Clin Exp Immunol; 1980 Oct; 42(1):27-32. PubMed ID: 6450653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody.
    Morimoto C; Steinberg AD; Letvin NL; Hagan M; Takeuchi T; Daley J; Levine H; Schlossman SF
    J Clin Invest; 1987 Mar; 79(3):762-8. PubMed ID: 2950134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The isolation and characterization of the human suppressor inducer T cell subset.
    Morimoto C; Letvin NL; Distaso JA; Aldrich WR; Schlossman SF
    J Immunol; 1985 Mar; 134(3):1508-15. PubMed ID: 3155770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of anti-lymphocyte antibody of patients with active SLE. I. Cause of loss of suppressor T-lymphocyte function.
    Morimoto C; Abe T; Toguchi T; Kiyotaki M; Homma M
    Scand J Immunol; 1979; 10(3):213-21. PubMed ID: 160612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoregulatory T cell subpopulations in man: dissection by monoclonal antibodies and Fc-receptors.
    Ballieux RE; Heijnen CJ
    Immunol Rev; 1983; 74():5-28. PubMed ID: 6226587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of proliferative and suppressor responses in the autologous mixed lymphocyte reaction by serum from patients with systemic lupus erythematosus.
    Stephens HA; Fitzharris P; Knight RA; Snaith ML
    Ann Rheum Dis; 1982 Oct; 41(5):495-501. PubMed ID: 6215003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune status in Crohn's disease. VI. Immunoregulation evaluated by multiple, distinct T-suppressor cell assays of lymphocyte proliferation, and by enumeration of immunoregulatory T-lymphocyte subsets.
    Auer IO; Röder A; Fröhlich J
    Gastroenterology; 1984 Jun; 86(6):1531-43. PubMed ID: 6232166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.